CBG Complementing CBD in a Novel Delivery Format
Our newest Specialty Formula supplies a cannabinoid blend of 1,000 mg CBG + 1,000 mg CBD. In this full spectrum oral spray, the minor cannabinoid CBG (cannabigerol) along with CBD (cannabidiol) contribute common beneficial properties, plus each adds their own unique effects for more comprehensive therapeutic support.*
CBD does not bind to activate the body’s cannabinoid receptors CB1 and CB2, but rather indirectly antagonizes them. However, CBG does bind to activate the CB1 receptors in the nervous system and CB2 receptors in the immune system. This distinction enables CBG to have some differing and complementary effects on the body than those of CBD.
ECS-Plex 2000 spray was created with our proprietary SoluSorb™ liposomal technology to provide a water soluble delivery system with a reduced, microscopic particle size of the active cannabinoids for enhanced bioavailability.
*These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.